Pulmonx Corporation revenue for the last year amounted to 68.67 M USD, the most of which — 68.67 M USD — came from its highest performing source at the moment, Interventional Pulmonology, the year earlier bringing 53.66 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Pulmonx Corporation 45.92 M USD, and the year before that — 32.49 M USD.